Allogeneic mesenchymal stem cells for treatment of AKI after cardiac surgery

Journal of the American Society of Nephrology

Volumn 29, Issue 1, 2018, Pages 260-267

  Swaminathan, Madhav ^a   Stafford Smith, Mark ^a   Chertow, Glenn M ^b   Warnock, David G ^c   Paragamian, Viken ^d   Brenner, Robert M ^d   Lellouche, François ^e   Fox Robichaud, Alison ^f   Atta, Mohamed G ^g   Melby, Spencer ^h   Mehta, Ravindra L ⁱ   Wald, Ron ^j   Verma, Subodh ^k   Mazer, C David ^k   Lombard, F Willem ^l   Schroder, Jacob ^l   Kurtzberg, Joanne ^l   Bisnar, Tiffany ^l   Conte, John ^m   Dodd O, Jeffrey ^m   Rabb, Hamid ^m   Katz, Nevin ^m   Shah, Ashish ^m   Huyette Arrizza, Elizabeth ^m   Bellot, Chris ⁿ   Kramer, Robert ^o   Tolson, Betsey ^o   Solomon, Richard ^p   Brooks, Charles ^q   Mora Mangano, Christina ^b   Wong, Jimmy ^b   Kashani, Kianoush ^r   Naka, Yoshifumi ^s   Umanath, Kausik ^t   Yee, Jerry ^t   Kilic, Ahmet ^u   Lecker, Stewart ^v   Frendl, Gyorgy ^w   MacKensen, Burkhard ^x   Simon, Mathieu ^f   Dagenais, Francois ^f   Ferland, Marie Claude ^f   Bouchard, Pierre Alexandre ^f   Whitlock, Richard ^y   Ainsworth, Craig ^y   McDonald, Ellen ^y   Curley, Gerard ^z   Yagnik, Sanjay ^z   Crescini, Charmagne ^z   Ferland, André ^aa   Maier, Karen ^aa   Denault, André ^ab   Ly, Hung ^ab   Bainbridge, Daniel ^ac   Bentall, Tracey ^ac   Légaré, Jean François ^ad   Grocott, Hilary ^ae   more..

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

^c Department of Medicine   (United States)

^d University of Alabama at Birmingham   (United States)

^e AlloCure Inc   (United States)

^f LAVAL UNIVERSITY   (Canada)

^g HAMILTON HEALTH SCIENCES   (Canada)

^h JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^j ST MICHAEL'S HOSPITAL   (Canada)

^k ST MICHAEL'S HOSPITAL   (Canada)

^l DUKE UNIVERSITY   (United States)

^m JOHNS HOPKINS UNIVERSITY   (United States)

ⁿ UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^o MAINE MEDICAL CENTER   (United States)

^p FLETCHER ALLEN HEALTH CARE   (United States)

^q UNIVERSITY OF VIRGINIA   (United States)

^r MAYO CLINIC   (United States)

^s Mayo Clinic ^*  (United States)

^t HENRY FORD HOSPITAL   (United States)

^u OHIO STATE UNIVERSITY   (United States)

^v Medical Center   (United States)

^w BRIGHAM AND WOMEN S HOSPITAL   (United States)

^x UNIVERSITY OF WASHINGTON   (United States)

^y HAMILTON GENERAL HOSPITAL   (Canada)

^z ST MICHAEL'S HOSPITAL   (Canada)

^aa LIBIN CARDIOVASCULAR INSTITUTE OF ALBERTA   (Canada)

^ab MONTREAL HEART INSTITUTE   (Canada)

^ac LONDON HEALTH SCIENCES CENTRE   (Canada)

^ad QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

^ae UNIVERSITY OF MANITOBA   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AC 607; CELL THERAPY AGENT; CREATININE; PLACEBO; UNCLASSIFIED DRUG;

ACUTE KIDNEY FAILURE; ADULT; AGED; ALL CAUSE MORTALITY; ARTICLE; CLINICAL EFFECTIVENESS; CONFIDENCE INTERVAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIALYSIS; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; HAZARD RATIO; HEART SURGERY; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MESENCHYMAL STEM CELL; MULTICENTER STUDY; NORTH AMERICA; OUTCOME ASSESSMENT; PATIENT SAFETY; PHASE 2 CLINICAL TRIAL; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; BLOOD; CLINICAL TRIAL; CONVALESCENCE; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; MESENCHYMAL STEM CELL TRANSPLANTATION; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; SURVIVAL RATE; TIME FACTOR; TREATMENT FAILURE;

ACUTE KIDNEY INJURY; AGED; CARDIAC SURGICAL PROCEDURES; CREATININE; DOUBLE-BLIND METHOD; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MIDDLE AGED; RECOVERY OF FUNCTION; RENAL DIALYSIS; SURVIVAL RATE; TIME FACTORS; TREATMENT FAILURE;

EID: 85040106302     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2016101150     Document Type: Article

References (24)

1. Parikh CR, Coca SG, Thiessen-Philbrook H, Shlipak MG, Koyner JL, Wang Z, Edelstein CL, Devarajan P, Patel UD, Zappitelli M, Krawczeski CD, Passik CS, Swaminathan M, Garg AX; TRIBE-AKI Consortium: Postoperative biomarkers predict acute kidney injury and poor outcomes after adult cardiac surgery. J Am Soc Nephrol 22: 1748-1757, 2011
2. Hobson CE, Yavas S, Segal MS, Schold JD, Tribble CG, Layon AJ, Bihorac A: Acute kidney injury is associated with increased long-term mortality after cardiothoracic surgery. Circulation 119: 2444-2453, 2009
3. Bihorac A, Yavas S, Subbiah S, Hobson CE, Schold JD, Gabrielli A, Layon AJ, Segal MS: Long-term risk of mortality and acute kidney injury during hospitalization after major surgery. Ann Surg 249: 851-858, 2009
4. Swaminathan M, Shaw AD, Phillips-Bute BG, McGugan-Clark PL, Archer LE, Talbert S, Milano CA, Patel UD, Stafford-Smith M: Trends in acute renal failure associated with coronary artery bypass graft surgery in the United States. Crit Care Med 35: 2286-2291, 2007
5. Schmitt R, Coca S, Kanbay M, Tinetti ME, Cantley LG, Parikh CR: Recovery of kidney function after acute kidney injury in the elderly: A systematic review and meta-analysis. Am J Kidney Dis 52: 262-271, 2008
6. Swaminathan M, Hudson CC, Phillips-Bute BG, Patel UD, Mathew JP, Newman MF, Milano CA, Shaw AD, Stafford-Smith M: Impact of early renal recovery on survival after cardiac surgery-associated acute kidney injury. Ann Thorac Surg 89: 1098-1104, 2010
7. Herrera MB, Bussolati B, Bruno S, Fonsato V, Romanazzi GM, Camussi G: Mesenchymal stem cells contribute to the renal repair of acute tubular epithelial injury. Int J Mol Med 14: 1035-1041, 2004
8. Lange C, Tögel F, Ittrich H, Clayton F, Nolte-Ernsting C, Zander AR, Westenfelder C: Administered mesenchymal stem cells enhance recovery from ischemia/reperfusion-induced acute renal failure in rats. Kidney Int 68: 1613-1617, 2005
9. Tögel F, Hu Z, Weiss K, Isaac J, Lange C, Westenfelder C: Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol Renal Physiol 289: F31-F42, 2005
10. Tögel F, Weiss K, Yang Y, Hu Z, Zhang P, Westenfelder C: Vasculo-tropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury. Am J Physiol Renal Physiol 292: F1626-F1635, 2007
11. Kale S, Karihaloo A, Clark PR, Kashgarian M, Krause DS, Cantley LG: Bone marrow stem cells contribute to repair of the ischemically injured renal tubule. J Clin Invest 112: 42-49, 2003
12. Barnes CJ, Distaso CT, Spitz KM, Verdun VA, Haramati A: Comparison of stem cell therapies for acute kidney injury. Am J Stem Cells 5: 1-10, 2016
13. Tögel FE, Westenfelder C: Mesenchymal stem cells: A new therapeutic tool for AKI. Nat Rev Nephrol 6: 179-183, 2010
14. Monsel A, Zhu YG, Gennai S, Hao Q, Liu J, Lee JW: Cell-based therapy for acute organ injury: Preclinical evidence and ongoing clinical trials using mesenchymal stem cells. Anesthesiology 121: 1099-1121, 2014
15. Shi Q, Rafii S, Wu MH, Wijelath ES, Yu C, Ishida A, Fujita Y, Kothari S, Mohle R, Sauvage LR, Moore MA, Storb RF, Hammond WP: Evidence for circulating bone marrow-derived endothelial cells. Blood 92: 362-367, 1998
16. Orlic D, Kajstura J, Chimenti S, Limana F, Jakoniuk I, Quaini F, Nadal-Ginard B, Bodine DM, Leri A, Anversa P: Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci U S A 98: 10344-10349, 2001
17. Gooch A, Doty J, Flores J, Swenson L, Toegel FE, Reiss GR, Lange C, Zander AR, Hu Z, Poole S, Zhang P, Westenfelder C: Initial report on a phase I clinical trial: Prevention and treatment of post-operative acute kidney injury with allogeneic mesenchymal stem cells in patients who require on-pump cardiac surgery. Cell Ther Transplant 1: 31-35, 2008
18. Shabbir A, Cox A, Rodriguez-Menocal L, Salgado M, Van Badiavas E: Mesenchymal stemcellexosomesinduce proliferationandmigration of normal and chronic wound fibroblasts, and enhance angiogenesis in vitro. Stem Cells Dev 24: 1635-1647, 2015
19. Pal R, Gopinath C, Rao NM, Banerjee P, Krishnamoorthy V, Venkataramana NK, Totey S: Functional recovery after transplantation of bone marrow-derived human mesenchymal stromal cells in a rat model of spinal cord injury. Cytotherapy 12: 792-806, 2010
20. Chen B, Hu J, Liao L, Sun Z, Han Q, Song Z, Zhao RC: Flk-1+ mesenchymal stem cells aggravate collagen-induced arthritis by up-regulating interleukin-6. Clin Exp Immunol 159: 292-302, 2010
21. Nam YS, Kim N, Im KI, Lim JY, Lee ES, Cho SG: Negative impact of bone-marrow-derived mesenchymal stem cells on dextran sulfate sodium-induced colitis. World J Gastroenterol 21: 2030-2039, 2015
22. Nasef A, Ashammakhi N, Fouillard L: Immunomodulatory effect of mesenchymal stromal cells: Possible mechanisms. Regen Med 3: 531-546, 2008
23. Casiraghi F, Perico N, Cortinovis M, Remuzzi G: Mesenchymal stromal cells in renal transplantation: Opportunities and challenges. Nat Rev Nephrol 12: 241-253, 2016
24. Chen C, Hou J: Mesenchymal stem cell-based therapy in kidney transplantation. Stem Cell Res Ther 7: 16, 2016